A company spokesperson told Fierce Medtech that Abbott estimates the issue will affect less than 1% of FreeStyle Libre 3 users in the U.S. (Abbott) Abbott is asking users of its FreeStyle Libre 3 ...
Abbott has initiated a medical device correction for sensors used in certain FreeStyle Libre 3 continuous glucose monitoring (CGM) systems in the US after determining that a number of them may be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results